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Liposomes have received extensive attention as nanocarriers for bioactive compounds due to their good
biocompatibility, possibility of targeting and incorporation of hydrophilic and hydrophobic compounds.
Although generally considered as safe, detailed knowledge of the eﬀects induced in cells and tissues with
which they interact is still underexplored. The aim of this study is to gain insight into the toxicity proﬁle of
dioctadecyldimethylammonium (DODAX) : monoolein(MO) liposomes (X is bromide or chloride), pre-
viously validated for gene therapy, by evaluating the eﬀect of the counter ions Br− or Cl−, and of the cat-
ionic : neutral lipid molar fraction, both in vitro and in vivo. Eﬀects on cellular metabolism and
proliferation, plasma membrane integrity, oxidative stress, mitochondrial membrane potential dysfunction
and ability to trigger apoptosis and necrosis were evaluated in a dose-/time-dependent manner in normal
human skin ﬁbroblasts. Also, newly fertilized zebraﬁsh zygotes were exposed to liposomes, permitting a
fast-track evaluation of the morphophysiological modiﬁcations. In vitro data showed that only very high
doses of DODAX : MO induce apoptosis and necrosis, inhibit cell proliferation, and aﬀect the metabolism
and plasma membrane integrity of ﬁbroblasts in a dose-/time-dependent manner. Furthermore, lipo-
somes aﬀected mitochondrial function, increasing ROS accumulation and disturbing mitochondrial mem-
brane potential. DODAC-based liposomes were consistently more toxic when compared to DODAB-
based formulations; furthermore, the inclusion of MO was found to reduce toxicity, in contrast to lipo-
somes with cationic DODAX only, especially in DODAB : MO (1 : 2) nanocarriers. These results were corro-
borated, in a holistic approach, by cytotoxicity proﬁling in ﬁve additional human cell lines, and also with
the zebraﬁsh embryotoxicity testing, which constitutes a sensitive and informative tool and accurately
extends cell-based assays.
1. Introduction
The development of nanotechnological solutions for bio-
medical applications has been a major focus of interest over
recent years. New nanocarriers are constantly developed for
therapeutic applications, and every year more nanomedicines
are approved for human therapy.1 Nevertheless, potential
adverse impact of nanomaterials on human health is yet to be
fully understood,2 and the molecular events involved in nano-
particle toxicity need further in depth studies. While most
chemicals are cytotoxic due to interactions with specific
biomolecules, one single nanoparticle might induce the pro-
duction of reactive oxygen species (ROS), morphological altera-
tions, genotoxicity and immunological eﬀects.3 In fact,
although several factors contribute to the toxicity of nano-
particles, their nanometric size is one of the most important
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parameters, since the high surface area to mass ratio strongly
influences interactions with biological molecules such as
proteins and cells. Additionally, binding to/interaction with
biological molecules alter nanoparticles’ surface properties,
influencing the interface with the cellular microenvironment.4
Other variables apart from size such as type of material, shape,
surface charge, hydrophobicity or concentration must also be
considered.5
Even though “cytotoxicity of nanoparticles” has been the
subject of excellent reviews in recent years, these are generally
focused on metallic nanoparticles, quantum dots or carbon
nanotubes, whilst liposomes have not been systematically
evaluated.6–8 The cytotoxicity mechanism of liposomes is
usually reported to be surface charge dependent.9,10 Liposomes
influence several signaling pathways,11 inducing apoptosis
depending on their association with cells and ROS pro-
duction.9,12 Moreover, the type of hydrophobic chain, hydro-
philic group and linker also have influence on the cytotoxic
response.9,13
Although in vitro cell-based testing is a proficient, informa-
tive and fairly cost-eﬀective approach to be considered for
initial screening of nanotoxicity,14 it does not replace the high
degree of biological organization that in vivo 3D-models
represent. Because cell culture systems do not take into con-
sideration the responses at the whole-organism scale, they can
lead to misleading conclusions.
To date, many studies addressing the in vivo toxicity assess-
ment of nanoparticles are contradictory or have limited scope,
mainly due to the unclarity of the regulatory guideline(s),15
which when combined with the lack of eﬃcient acute/chronic
screening protocols and putative standards, limits the pre-
clinical testing of nanotherapeutics. Zebrafish Danio rerio
Hamilton 1822 is a small vertebrate (Pisces: Teleostei) model
that requires less expensive husbandry and accommodation
than do mammals, commonly used for toxicity evaluation.
Zebrafish oﬀers genetic, physiological and anatomical
resemblance with mammals including the blood brain barrier,
endothelial cells and immunogenic responses.16 Moreover,
zebrafish biology has other advantageous characteristics:
(i) females have the capability to lay around 200–300 eggs per
day every 5–7 days; (ii) equals the longevity and generation
time of mice (3–5 months); and (iii) transparent embryos
develop promptly into larvae, ex-utero, within 120 hours post-
fertilization (hpf)17,18 allowing in vivo real-time imaging of
ongoing processes and significant reduction of experiment
duration. The zebrafish embryo toxicity (ZET) assay has been
extensively used for conservative risk assessment of metallic
nanoparticles, carbon-based nanostructures and polymers,
screening ecological benchmarks.19–22
We have previously observed that liposomes and siRNA-
lipoplexes composed of dioctadecyldimethylammonium
bromide or chloride (DODAB/DODAC) : monoolein (MO)
induce dissimilar in vitro responses.23 The counter ion (Cl− or
Br−) of the cationic lipid not only influences the structure,
stability and silencing eﬃciency of siRNA-lipoplexes, but it also
seems to aﬀect their cytotoxicity. There are also indications
that the fraction cationic/neutral lipid on the liposomal
formulation can play a role in cellular responses. Therefore, in
the present study, we investigated the influence of the counter
ion (Br− or Cl−) and of the cationic/neutral lipid molar fraction
on the cytotoxic response of several human cell lines to
DODAX :MO liposomes, and the ZET assay was performed
to validate the results in vivo. Cellular metabolic activity,
proliferation and plasma membrane integrity, induction of
ROS accumulation, changes of the mitochondrial membrane
potential, and cell death mechanisms (apoptosis versus
necrosis) were evaluated in vitro. In the ZET protocol, zebrafish
embryos were monitored via continuous waterborne exposure
to DODAX : MO liposomes, for 80 hpf. The following endpoints
were assessed: mortality, developmental delay signals, pheno-
typical malformations, spontaneous movements and free-
swimming patterns, cardiac rhythm and hatching rate – using
a “non-animal” (according to European Directive 2010/63/EU
on the protection of animals used for scientific purposes)
“intermediate” system, positioned amid cellular and mammal
models.24
We propose that a more complete and reliable approach to
assess the eﬀects of exposure to non-metallic particles should
integrate both in vitro and in vivo parameters, suggesting
the ZET assay as an informative platform for screening nano-
toxicity eﬀects.
2. Materials and methods
2.1 Chemicals and reagents
Dioctadecyldimethylammonium bromide (DODAB), dioctadecyl-
dimethylammonium chloride (DODAC), and 1-monooleoyl-rac-
glycerol (MO) were supplied by Sigma-Aldrich (Bornem,
Belgium). DMEM® and M199® cell culture media, L-glutamine
(L-Glu), Fetal Bovine Serum (FBS), trypsin–EDTA solution,
Penicillin–Streptomycin (P/S) (5000 IU mL−1 penicillin and
5000 µg mL−1 streptomycin) and Hygromycin B® were pur-
chased from Gibco (UK). The MTS assay kit was obtained from
Promega (USA), and SRB solution was purchased from Sigma-
Aldrich (USA). The Annexin-FITC kit was obtained from BD
Biosciences (USA) and MitoTracker Red CMXRos from Mole-
cular Probes (UK).
2.2 Preparation and biophysical characterization of
liposomes
Liposomes were prepared by ethanolic injection.25 Briefly,
defined volumes of DODAC, DODAB and MO (20 mM stock
solutions in ethanol) were injected into HEPES buﬀer, 25 mM
pH 7.4, under strong vortex and above the transition tempera-
ture of the lipids (>50 °C), to a final total lipid concentration
of 3 mM. The cationic : neutral lipid mixtures will be referred
to as B : M (1 : 0), B : M (2 : 1), B : M (1 : 2), C : M (1 : 0), C : M
(2 : 1), and C :M (1 : 2), where B represents DODAB, C
represents DODAC and M stands for monoolein. The molar
ratios 1 : 0, 1 : 2 and 2 : 1 are represented between brackets
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(mol : mol). Liposomes were stabilized at room temperature
(RT) before use.
The mean size, polydispersity index (PDI) and zeta (ζ-)
potential of liposomes (1 mM) were determined by dynamic
light scattering (DLS) in a Zetasizer Nano ZS (Malvern, UK),
equipped with Dispersion Technology Software (DTS), at 25 °C.
All results were based on intensity distributions.
2.3 In vitro nanocytotoxicity evaluation
2.3.1 Culture conditions and incubation with liposomes.
The human foreskin fibroblast cell line BJ5-ta (ATCC®
CRL-4001™) was grown on a mixture (4 : 1 v : v) of DMEM®
(supplemented with 4 mM L-Glu, 4.5 g L−1 glucose and 1.5
g L−1 sodium bicarbonate) and Medium 199® (supplemented
with 0.01 mg mL−1 Hygromycin B and 10% FBS) with 1% P/S
solution. Cells were kept in a humidified incubator (37 °C, 5%
CO2) and sub-cultured every 3–4 days in order to maintain sub-
confluency.
Several cytotoxicity assays were performed after BJ5-ta cells
were exposed to B : M (1 : 0), B : M (2 : 1), B : M (1 : 2), C : M
(1 : 0), C : M (2 : 1) and C : M (1 : 2) liposomes. For MTS and
SRB assays, cells were seeded into 96-multiwell microplates
(TPP, Switzerland), at a density of 10 × 103 cells per well; for
LDH and DCFH-DA assays, cell were seeded at 100 × 103 cells
per well in 24-multiwell microplates (TPP, Switzerland). For the
Annexin/PI assay and mitochondrial membrane potential
(ΔΨm) determination, BJ5-ta cells were seeded at a density of
100 × 103 cells per well in 6-multiwell microplates (TPP,
Switzerland).
In all assays the culture medium was renewed prior to the
addition of liposomes (5, 20 and 40 μg mL−1 for SBR; 5, 20, 40,
80 and 160 μg mL−1 for MTS and LDH; 40 and 80 μg mL−1 for
DCFH-DA; and 40 μg mL−1 for Annexin/PI and ΔΨm assays).
30% (v : v) DMSO was used as death control.
2.3.2 Assessment of metabolic cytotoxicity with MTS assay.
The metabolic cytotoxicity was assessed with the MTS assay
after 8, 24 or 48 h incubation with liposomes, and according
to the manufacturer’s instructions. The percentage of
metabolic activity was expressed in relation to non-treated cells
(NT).
2.3.3 Determination of cell proliferation by SRB assay.
Cellular proliferation was determined by the sulphorhodamine
B (SRB) assay after 8, 24 and 48 h contact with liposomes.
Briefly, the medium was removed, cells were washed with
phosphate-buﬀered saline (PBS) and a solution of 1% acetic
acid in methanol was added to each well. After 1 h at −20 °C,
the wells were washed with PBS and dried, and 5% SRB solu-
tion (in 1% acetic acid) was added to each well. The micro-
plates were incubated for 90 min at 37 °C. After washing oﬀ
the excess of SRB, 10 mM Tris was used to dissolve SRB,
and absorbance was read at 540 nm using a multiplate
reader (SpectraMax Plus 384, Molecular Devices). Timepoint
0 h (before addition of liposomes) was considered as 100%
cell proliferation. The percentage of cell proliferation was
expressed relative to non-treated cells (NT).
2.3.4 Evaluation of cell membrane integrity by LDH assay.
The lactate dehydrogenase (LDH) assay was used to determine
cellular membrane integrity after 8, 24 and 48 h incubation
with liposomes, as previously described.25 The percentage
of membrane integrity was expressed as a percentage of the
intracellular LDH activity relative to the total (extracellular +
intracellular) LDH activity.
2.3.5 Evaluation of apoptosis/necrosis by Annexin V/PI
assay. The Annexin V/propidium iodide (PI) assay was used to
determine apoptosis/necrosis. After 24 and 48 h incubation
with liposomes floating and adherent cells were collected and
washed with PBS. 1 × 105 cells were suspended in binding
buﬀer, incubated with Annexin V-FITC (green) and PI (red)
according to the manufacturer’s instructions, and analyzed by
flow cytometry.
2.3.6 Determination of intracellular ROS by DCFH-DA
assay. The accumulation of reactive species of oxygen (ROS)
was determined by the DCFH-DA assay.26 After a 2, 4 and 8 h-
period incubation with liposomes, the cell culture medium
was removed and the cells were washed twice with PBS.
DCFH-DA (100 µM) was added to each well and the micro-
plates incubated at 37 °C for 30 min, in the dark. Extracellular
DCFH-DA was removed by washing the wells twice with PBS,
and cells were lysed with 90% DMSO/10% PBS solution. The
fluorescence was read with a black 96-well microplate (TPP,
Switzerland) in a Fluoroskan Ascent FL (Thermo Scientific),
with λexc = 485 nm and λem = 538 nm.
2.3.7 Analysis of mitochondrial membrane potential (ΔΨm)
alterations. MitoTracker Red CMXRos was used to determine
the mitochondrial membrane potential (ΔΨm) after incubation
with liposomes. After the 24 and 48 h-period incubation, float-
ing and adherent cells were collected and washed with PBS.
1 × 105 cells were suspended in PBS, incubated with Mito-
tracker Red CMXRos according to instructions and analyzed by
flow cytometry.
2.3.8 Flow cytometry analysis. Samples double stained
with Annexin V/PI or stained with MitoTracker Red CMXRos
were analyzed using a flow cytometer (Epics XL, Beckman
Coulter, Miami, FL, USA) equipped with an argon-ion laser
(488 nm beam, 15 mW). FL-1 (488/525 nm) and FL-4 (488/
620 nm) were used to detect green and red fluorescence,
respectively. For each sample 20 000 cells were run, and data
was analyzed with the Flowing software (version 2.5.1, Turku
Centre for Biotechnology).
2.4 In vivo nanotoxicity assessment
All experiments were performed in compliance with the guide-
lines on the protection of experimental animals by the Council
of Europe, Directive 86/609/EEC, which allows zebrafish
embryos to be used up to the moment of free-living. As the
ZET assays were carried out up to 80 hpf (i.e. within the regu-
latory limit of exposure, set at 120 hpf, which corresponds to
the end of the embryonic development), no license is required.
2.4.1 ZET protocol and collected data. In vivo nanotoxicity
and bioactivity of DODAX : MO liposomes were assessed
with the zebrafish embryo toxicity (ZET) assay.20 Fertilized
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eggs were randomly allocated into 24-well microplates
(≈16-cell stadium, cleavage period; 5 eggs per mL), with con-
tinuous waterborne exposure to liposomes at diﬀerent molar
ratios (4 : 1, 2 : 1, 1 : 1, 1 : 2 and 1 : 4 mol : mol), for 80 hpf.
For each set of test conditions, all embryos were derived
from the same eggs spawn. For experimental validation, viable
eggs were obtained only from spawns with a > 90% fertiliza-
tion rate. The individual and combined contribution of the
nanoformulation components was screened (see Table 1).
The (embryo)toxicity of ethanol (solvent of the lipids’ stock
solutions) and HEPES buﬀer (used to prepare the liposomes)
was first investigated (ESI, Table S1†) to set the toxicity limits
for liposome production. Four replicates were considered for
each condition, including experimental and solvent controls.
The tested conditions were defined based on in vitro (nano)
cytotoxicity profiles. The freshwater system was demonstrated
not to aﬀect the chorion and plasma membrane permeability
of zebrafish embryos, enhancing their development and
hatching rates more than high-calcium standard media, but
common protozoan contamination is diﬃcult to avoid.27 Ultra-
pure water was used in all treatments to maintain zebrafish
embryos mortality below 10%. To ensure optimal incubation
temperature of the zebrafish embryos, all the test solutions
and suspensions were pre-heated to 28 ± 1 °C.
To analyze the eﬀect of DODAX : MO liposome exposure on
zebrafish embryos epiboly, the percentage of the epibolic arc
at 8 hpf was estimated. This variable can provide an early
warning signal of a developmental delay, given that at this
embryonic stage the epibolic arc is known to correspond
to 75% for the normal development of zebrafish.28 The head–
trunk angle (HTA) of 32 hpf zebrafish embryos was also
measured in order to detect atypical development, given that
this index was defined by Kimmel as a function of hours of
development.28 Additionally, 20 embryos from each treatment
(10 per quadruplicates) were randomly selected and the
number of heart beats was counted during 10 s. In order to
avoid bias, “blind” observations were performed by a single
person. At 8, 32, 56 and 80 hpf, 20 zebrafish embryos from
each condition were photographed using a Leica DM IL LED
inverted microscope coupled with an ICC50 HD camera.
Measurements of the chorion, yolk, eye, pupil, head–trunk
angle and body length (respective to each hpf) were obtained
using Image Tool (UTHSCSA, v3.00). The following morpho-
logical and physiological developmental endpoints were
further assessed: mortality, developmental delay signals,
phenotypical malformations, spontaneous movements and
free-swimming patterns, cardiac rhythm and hatching rate.
These variables were selected, given their potential impli-
cations in vital processes such as neuro-motor coordination.
In all ZET experiments, dead embryos were removed to avoid
cross-contamination, a process repeated three times every
24 h.
3. Results
Liposomes were found to have mean sizes <200 nm, a poly-
dispersity index (PDI) < 0.5 and to be positively charged
(>+50 mV), with no clear trend between formulations (ESI,
Table S2†). These characteristics were consistent with the
formulations prepared using a similar methodology in
previous studies.25,29 Nevertheless the structural organization
of DODAX :MO liposomes is known to be dependent on the
counter ion and MO molar fraction (Fig. 1): the reduced
screening capacity of a Cl− ion when compared to a Br− ion
results in a less ordered polar region for DODAC when com-
pared to DODAB bilayers. These packing characteristics deter-
mine how MO is incorporated into the nanosystems: for high
cationic lipid contents MO is homogeneously distributed into
DODAC bilayers, while it forms DODAB- and MO-enriched
domains in DODAB bilayers; when MO is in excess (molar
fraction (1 : 2)), DODAB/DODAC-rich bilayers are formed, in-
corporating MO-rich inverted structures.23
3.1 DODAX :MO liposomes decrease cellular viability by
more than one mechanism
To obtain a more holistic and integrated perspective on the
possible adverse in vitro eﬀects of liposomes, metabolic
Table 1 Nanoformulation components screened with the ZET assay
Component Conditions tested
DODAX lipids (µM) 0.5 1 3 5 9
MO lipids (µM) 5 15 25 50 75
Ratio of DODAX :MO lipids
(mol : mol)
4 : 1 2 : 1 1 : 1 1 : 2 1 : 4
Percentage of ethanol (v/v) 0.25 0.5 1.5 3 5
HEPES buﬀer (mM) 0.5 1 3 5 15
Fig. 1 Schematic representation of DODAX : MO liposomes’ structural
organization (in green: DODAB, in blue: DODAC, in red: monoolein).
Paper Toxicology Research
Toxicol. Res. This journal is © The Royal Society of Chemistry 2016
Pu
bl
ish
ed
 o
n 
13
 Ju
ne
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
N
IV
ER
SI
TY
 O
F 
N
EB
RA
SK
A
 o
n 
14
/0
6/
20
16
 1
2:
19
:3
9.
 
View Article Online
activity, cellular proliferation and plasma membrane integrity
were assessed using immortalized normal human fibroblast
cells (BJ5-ta) exposed for 8, 24 and 48 h to DODAX :MO lipo-
somes (Fig. 2). Cells were exposed to 5, 20, 40, 80 and 160
µg mL−1 of B : M (1 : 0), B : M (2 : 1), B : M (1 : 2), C : M (1 : 0),
C : M (2 : 1) and C :M (1 : 2) liposomes, and metabolic activity
was determined by the MTS assay, cellular proliferation by the
SRB assay and plasma membrane integrity by the LDH assay.
For MTS, the percentage of metabolic activity was expressed
relative to non-treated cells (NT), set to 100%; for SRB, time-
point 0 h (before addition of liposomes) was considered as
100% cell proliferation, and the percentage of cell proliferation
was expressed relative to non-treated cells (NT); for LDH, the
percentage of plasma membrane integrity was expressed
as the percentage of intracellular LDH activity relative to the
total (extracellular + intracellular) LDH activity. Results are
expressed as mean ± S.E.M. of three independent experiments.
DODAX :MO liposomes induced a concentration- and time-
dependent eﬀect on fibroblast viability.
MTS results showed that the cytotoxic eﬀects at the level of
cellular metabolism become less evident with longer incu-
bation times (Fig. 2A versus 2B versus 2C). In general, lipo-
somal formulations with higher MO contents (B : M (1 : 2) and
C : M (1 : 2)) caused lower cytotoxicity, supporting the notion
that inclusion of MO, apart from improving eﬃciency,
also enhances cytocompatibility. For the same molar fraction
and after 48 h incubation, DODAC- were clearly more cytotoxic
than DODAB-based formulations. For other timepoints, no
clear trend was observed.
DODAX :MO negative eﬀects on BJ5-ta proliferation,
assessed by SRB, were only clearly visible for long exposure
times (Fig. 2D versus 2E versus 2F), with DODAC-based lipo-
somes inducing a stronger negative eﬀect on cell proliferation
which was attenuated by the inclusion of MO in the formu-
lation. Plasma membrane integrity evaluated by the LDH assay
increased with increasing incubation time for all nanoformula-
tions (Fig. 2G–I). After 8 and 24 h, this parameter was not com-
promised with up to 40 µg mL−1 liposomes, while after 48 h
incubation with C :M (1 : 0) and C : M (2 : 1) resulted in a
significant loss of plasma membrane integrity. The presence
of MO also had a positive eﬀect on the cytotoxicity, but only
up to 40 µg mL−1. In any case, B : M (1 : 2) prompted less dis-
ruptive eﬀects on BJ5-ta plasma membranes and, for the same
molar fraction, DODAC-based liposomes lead to more evident
toxicity, at all exposure times.
It also became evident that the eﬀects of DODAX :MO lipo-
somes on the metabolic activity, cellular proliferation and
plasma membrane integrity were cell line-dependent (ESI,
Fig. 2 In vitro evaluation of DODAX : MO liposomes’ cytotoxicity. Metabolic activity (A–C), cellular proliferation (D–F) and plasma membrane integ-
rity (G–I) of BJ5-ta cells evaluated after 8 h, 24 h and 48 h incubation with DODAX : MO liposomes.
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Fig. S1–S3†). A dose-dependent metabolic response was
observed for the six tested cell lines (293 T, MDA-MB-435,
MDA-MB-468, K562, THP1 and BJ5-ta); for the same molar
fraction, DODAC-based liposomes induced higher metabolic
cytotoxicity and plasma membrane disruptive eﬀects than
DODAB-based liposomes; and no clear correlation between
DODAC and DODAB, or with the presence of MO, could be
established on cellular proliferation.
Induction of cell death after exposure of BJ5-ta to DODAX :
MO liposomes was also assessed with the Annexin V/propi-
dium iodide (PI) assay, in order to evaluate if diﬀerent lipo-
somal formulations induce the exposure of phosphatidylserine
at the outer leaflet of the plasma membrane, a typical marker
of apoptotic cells (Fig. 3).
Fig. 3 shows that, for the concentrations and timepoints
tested, all DODAX : MO liposomes lead to an increase in
the percentage of single (An+/PI−, early apoptotic cells; or
An−/PI+, necrotic cells) and double stained cells (An+/PI+ late
apoptotic cells), although almost no late apoptotic cells were
detected. Overall, the contribution of the death mechanisms
was very similar for all DODAX :MO liposomes, where the per-
centage of live cells (An−/PI−) increased from 24 to 48 h incu-
bation with DODAX :MO liposomes (Fig. 3B versus 3D). The
exception was noted in C :M (1 : 0) and C :M (2 : 1) liposomes,
with which less necrotic (An−/PI+) and more apoptotic
(An+/PI+) cells were observed after 48 h incubation. The pres-
ence of MO in the liposomal formulation resulted in a higher
number of live cells (An−/PI−): B : M (1 : 2) and C :M (1 : 2) >
B : M (2 : 1) and C : M (2 : 1) > B : M (1 : 0) and C :M (1 : 0). This
eﬀect was more evident after 48 h of exposure (Fig. 3D).
3.2 DODAX :MO liposomes trigger ROS accumulation and
aﬀect the mitochondrial membrane potential
Fig. 4 shows the accumulation of ROS by BJ5-ta cells after
short exposure times (2, 4 and 8 h) to liposomes, chosen
to limit massive cell death, and consequent reduced cell
numbers, which would drive one to misleading conclusions.
Fig. 4A shows time-dependent ROS accumulation after incu-
bation with 40 µg mL−1 DODAX :MO liposomes. C : M (2 : 1)
liposomes significantly upregulated ROS levels in comparison
with endogenous levels in NT cells after only 2 h of contact,
while C : M (1 : 0) caused the same eﬀect after 4 h. All other
formulations except B : M (1 : 2) led to a similar increase after
8 h of exposure.
Incubation of BJ5-ta cells with higher liposome concen-
trations (80 µg mL−1, Fig. 4B) showed that, for the same molar
fraction, DODAC-based liposomes led to higher ROS accumu-
lation. Nevertheless, at 8 h, existence of cell death interfered
with the ROS levels detected (Fig. 2A and G).
Fig. 3 Apoptosis/necrosis induced by DODAX : MO liposomes on BJ5-ta cells. Cells were incubated with 40 µg mL−1 liposomes and Annexin/PI
assay was performed after 24 h (A and B) and 48 h (C and D). A and C – Histograms of BJ5-ta cells labeled with Annexin V and PI after incubation
with DODAX : MO liposomes. B and D – Quantitative analysis of Annexin/PI staining of BJ5-ta cells. Values represent mean ± S.E.M. of four indepen-
dent experiments. H2O2 was used as control; NT – non-treated cells; An−/PI−: Annexin negative and PI negative staining (live cells); An+/PI−:
Annexin positive and PI negative staining (early apoptotic cells); An+/PI+: Annexin positive and PI positive staining (late apoptotic cells); An−/PI+:
Annexin negative and PI positive staining (necrotic cells).
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It was interesting to notice that, not only did other cell lines
(MDA-MB-468 and K562) produce less ROS after incubation
with DODAX :MO liposomes, but also that their behavior did
not follow the same trend as seen for BJ5-ta cells (ESI,
Fig. S4†). This observation reinforces the notion that the
eﬀects are cell specific.
Flow cytometry assays were performed in order to evaluate
possible alterations in the mitochondrial membrane potential
(ΔΨm) after incubation with DODAX :MO liposomes (Fig. 5).
A drop in ΔΨm generally occurred after incubation
with liposomes for 24 and 48 h (Fig. 5), but this was only
significantly diﬀerent from NT cells after a 24 h exposure to
C : M (2 : 1) liposomes.
3.3 In vivo evaluation of DODAX : MO liposomes toxicity
using the ZET assay
When analyzing the eﬀects of DODAX and MO, as free lipids
or formulated in liposomes, on zebrafish embryos survival, a
significant interaction was observed for DODAC (Fig. 6).
In line with the data obtained with all in vitro experiments,
DODAC showed higher embryotoxicity than DODAB, while MO
did not cause any apparent toxicity. Moreover, after 8 hpf the
Fig. 4 Induction of ROS production by BJ5-ta cells after exposure to
DODAX : MO liposomes. Cells were incubated with 40 µg mL−1 (A) and
80 µg mL−1 (B) liposomes and DCFH-DA assay was performed after 2, 4
and 8 h. Values represent mean ± S.E.M. of three independent experi-
ments. NT – non-treated cells.
Fig. 5 Induction of alterations in the mitochondrial membrane poten-
tial (ΔΨm) of BJ5-ta cells due to the presence of DODAX : MO liposomes.
Cells were incubated with 40 µg mL−1 of liposomes and the assay was
performed after 24 and 48 h. Values represent mean ± S.E.M. of two
independent experiments. NT – non-treated cells.
Fig. 6 Eﬀects of exposure to DODAX : MO liposomes on Danio rerio
embryos survival. Values represent mean ± S.D. of quadruplicate wells.
Error bars represent the coeﬃcient of variation for the ﬁndings in the
replicate wells. 0 : 0 (i.e. control group) – no DODAX: zebraﬁsh embryos
were exposed to freshwater only. No lip (i.e. control group) – no lipo-
somes: zebraﬁsh embryos were exposed to freshwater only.
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overall survival of zebrafish embryos exposed to DODAC
decreased in a concentration-dependent manner. The highest
concentration (i.e. 9 µM of DODAC) led to 100% mortality of
zebrafish eleutheroembryos (embryos post-hatch, but prior to
external feeding). Interestingly, when mixed with MO, DODAC
embryotoxicity was reduced, independently of the DODAC :MO
ratio. Furthermore, the zebrafish embryos exposed to DODAX :
MO liposomes, independently of the percentage of MO,
showed survival rates ≥75%. These results are coherent with
the cytotoxic profile obtained for in vitro cell-based tests.
Table 2 summarizes the eﬀect on the diﬀerent parameters
monitored during zebrafish embryogenesis (8–80 hpf) upon
exposure to diﬀerent concentrations of the tested conditions,
giving an overall and important perspective of the toxicity
of single components, when in a mixture or in liposomal
formulations.
4. Discussion
In this study we evaluated the eﬀect of cationic liposomes’
composition on the viability of several human cell lines,
exploiting both the influence of the counter ion (Br− or Cl−) in
the cationic surfactant and the fraction of cationic/neutral
lipid of DODAX :MO liposomes, previously validated for
nucleic acid delivery (Silva et al. 2011,25 2012,34 2014,29,32,33
Oliveira et al. 2014,23 2015,31 Lopes et al. 201530). Our aim was
to obtain a comprehensive perspective of the toxicity profile of
DODAX :MO liposomes and to understand how changing
the lipid mixture influenced cells (metabolism, proliferation,
cell death), tissues and organisms. Moreover, we set to high-
light the potential of in vivo nanotoxicity assessment of
liposomal nanocarriers in zebrafish embryotoxicity assays.
These nanocarriers have been scarcely studied using these
intermediate in vivo models, in stark contrast with metallic
nanocarriers, in recent years.
Results obtained with the in vitro assays point to two
general conclusions: DODAC-based liposomes induce higher
cytotoxicity than DODAB-based liposomes, for the same molar
fraction, in normal human fibroblasts; and the inclusion
of MO in the formulation reduces cytotoxicity. Although the
results were clearly cell-type dependent, the same trend
was found for the other cellular models tested (293 T,
MDA-MB-435, MDA-MB-468, K562 and THP1), in terms of
metabolic activity and plasma membrane integrity (Fig. S1 and
S3†), but not for proliferation assessment (Fig. S2†). Interest-
ingly, in vivo ZET assays showed that individual administration
of DODAX (i.e. as free compounds) significantly disrupted fish
development, with DODAC revealing a more toxic profile than
DODAB, in a concentration-dependent manner. In contrast,
DODAB or DODAC combined with MO in liposomes, in
general, did not exert such level of toxicity. Moreover, the
overall embryotoxicity profile of liposomes did not vary with
the DODAX :MO molar fraction.
We have shown earlier that DODAC :MO and DODAB : MO
have a diﬀerent lipid structural organization due to the pres-
ence of the counter ions Cl− or Br−: MO is more homo-
geneously distributed in DODAC than in DODAB bilayers,
which results in the formation of lamellar phases with less
tight polar headgroups in DODAC :MO liposomes.23 These
characteristics may directly influence the diﬀerent cytotoxic
response observed for DODAC- and DODAB-based liposomes,
as it is expectable an easier transference of DODAC to plasma
membranes, promoting higher destabilization. In addition to
having a less packed headgroup region, DODAC :MO liposomes
also form smaller and more curved aggregates than DODAB-
based liposomes,23,35,36 and are more fusogenic due to the more
homogeneous MO incorporation.23 A less ideal packing of lipid
molecules promotes an easier escape of cationic lipids when
compared with nanoformulations with more tightly packed
lipids and lower curvature bilayers.37 Also, DODAB liposomes
were shown to be more stable under physiological conditions,23
which may limit lipid loss, thereby decreasing cytotoxicity.38
MO is considered a safe and biocompatible lipid, with
several reports on its use for biomedical applications (Kulkarni
et al. 2011,41 Silva et al. 2011,25 2012,34 2014,29 Oliveira et al.
2014,23 2015,31 Carneiro et al. 2015,40 Lopes et al. 201530). MO’s
fusogenicity and capacity to increase the fluidity of the lipid
bilayers39 impelled us to further explore its influence on DODAX :
MO formulations when in interface with cells. Our results
show that MO presence in the nanoformulation was generally
beneficial for the cellular metabolism in all exposure times
and for proliferation (48 h) of fibroblasts, with cell survival
increasing in the order of DODAX :MO (1 : 0) < (2 : 1) < (1 : 2).
Table 2 Zebraﬁsh embryotoxicity testing. (+) Corresponds to the signiﬁcant eﬀect and (−) corresponds to the non-signiﬁcant eﬀect on tested inde-
pendent variables
hpf
Independent
variables Ethanol HEPES MO DODAB DODAC
DODAB :MO
liposomes
DODAC :MO
liposomes
Morphometric analysis 8 Epibolic arc + − − + + − −
8 Yolk volume + − − − + − −
32 Head–trunk angle + − − + + − −
56 Eye surface + − − − + − −
Muscular coordination 32 Cardiac rhythm + + − − + + +
32 Spontaneous movements − + − + + + +
80 Free-swimming + + − + + − −
80 Survival + − − + + − −
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While this trend was not so clear regarding plasma membrane
integrity, B : M (1 : 2) liposomes compromised it to a lesser
extent when compared to other liposomal formulations. This
might be explained by the fact that MO becomes mainly con-
fined to the liposomal core, not imprinting a high fusogenic
capacity to the system,23,42 decreasing the disruption caused at
the plasma membrane level. Nevertheless, for long incubation
times, as interaction with cell membranes is favored, lipid
rearrangements occur and MO might boost the integration of
cationic lipids into the plasma membrane, resulting in a syner-
gistic eﬀect between both DODAC and MO lipids in terms of
membrane toxicity. For shorter exposure times (4 h) MO always
attenuated the negative eﬀects associated with DODAC-based
liposomes on plasma membranes, but the same was not true
for DODAB-based liposomes.
Cells are heterogeneous entities whose composition of
plasma membranes depends on developmental and environ-
mental stimuli, varying significantly between cell types.43 This
strongly aﬀects the cellular response to nanomaterials,44 as
observed by the slightly diﬀerent response to DODAX : MO
liposomes in the six cell lines tested. Therefore, it becomes
evident that not only is the selection of the cell type very
important for toxicity assessment, but also the integration of
these results with data from in vivo models.
An important consideration in ZET assays is the presence of
the zebrafish chorion, an acellular envelope surrounding
mature eggs of teleosts that enables for e.g. oxygen/carbon
dioxide to pass through via passive diﬀusion.45 The zebrafish
chorion is composed of three intercrossed layers and possesses
pores with approximately 0.5–0.7 µm diameter,46 which should
not impair the passage of the tested nanocarriers. In the
present study, the clarification of specific and/or nonspecific
interactions between dechorionation and nanotoxicity of
DODAX :MO liposomes was not addressed. Nevertheless, our
data showed that normal patterns of spontaneous movements
and heart rhythm of 32 hfp zebrafish embryos varied with the
DODAX :MO molar fraction. This diﬀerential eﬀect allows one
to anticipate that the toxicity of DODAX : MO liposomes was
not conditioned by the presence of the chorion. On the other
hand, the eﬀect of zebrafish chorion removal has already been
demonstrated with Luviquat HM 552, which blocks it due to
the cationic polymer molecular weight (∼400 000 Da).47 Interest-
ingly, DODAX surfactants (with a higher molecular weight than
Luviquat HM 552) were shown to aﬀect multiple developmental
variables of non-dechorionated zebrafish embryos/larvae, in a
concentration-dependent manner. In agreement with the results
from in vitro experiments, MO might favor the interaction of the
cationic lipids with the chorion. Yet, the overall permeability
contribution of the zebrafish chorion to the embryotoxicity of
DODAX and MO, administered alone or combined in liposomal
formulations, still needs to be confirmed.
Since very high doses of DODAX :MO liposomes aﬀected
BJ5-ta cell metabolism, cellular proliferation and plasma mem-
brane integrity, promoting cell death, we investigated if it was
occurring through apoptosis or necrosis. Cationic liposomes
might induce apoptosis, often after 24–48 h exposure,9,12,48,49
but they can also trigger acute cell necrosis, even before the
occurrence of apoptosis, in a positive surface charge-depen-
dent manner.49 Accordingly, we found that DODAX :MO lipo-
somes induced cell death by both apoptosis and necrosis.
Interestingly, the percentage of live cells (An−/PI−) generally
increased from 24 h to 48 h of exposure, in line with what
was observed with the MTS assay: metabolic activity slightly
increased with longer incubation times. This might be
explained by a dilution of the cellular nanoparticle content
when cells are proliferating, therefore minimizing the negative
eﬀects on the metabolism of the surviving cells.2 The presence
of MO in the liposomal formulation resulted in a higher
number of live cells. An equivalent outcome was achieved
in vivo. Yet, the zebrafish embryos survival was independent of
the DODAX :MO liposomal molar fraction tested.
When cells are exposed to minor levels of oxidative stress,
their antioxidant protection is activated, but when ROS
production overcomes the cellular antioxidant capacity, its
accumulation can lead to cell death. Thus, ROS play an impor-
tant role in apoptosis.50 DODAX :MO liposomes induced
accumulation of ROS in a time-, concentration-, liposomal for-
mulation- and cell line-dependent manner. DODAC-based lipo-
somes seemed to prompt higher ROS accumulation in
fibroblasts, especially for 80 µg mL−1, while the MO content
did not have a clear eﬀect. Since mitochondria is another key
player in apoptosis and is related to oxidative stress,51 altera-
tions on mitochondrial potential induced by DODAX : MO
liposomes were evaluated. Although no significant eﬀect was
observed, our results suggest that DODAX :MO liposomes
aﬀected the mitochondrial membrane potential, especially
after 24 h incubation with C : M (2 : 1). Future work will deter-
mine the zebrafish chorion permeability eﬀects on embryonic
ROS levels upon continuous waterborne exposure to DODAX :
MO liposomes and free surfactants.
The future of nanocarriers as therapeutic agents in medi-
cine depends on the validation of multiparameter testing to
account for the eﬀects of administration routes, bioavailability,
distribution and degradability, induction of developmental
defects and activation of the complement and/or immune
system. These factors are critical for in vivo nanotoxicity assess-
ment and cannot be fully addressed with in vitro experiments.
The integration of results from the in vitro and in vivo experi-
ments will contribute to more comprehensive knowledge and
allow predictions regarding the interaction of nanocarriers
with cells, tissues and organisms. Zebrafish embryogenesis is
an attractive and highly-informative in vivo model for fast track
nanotoxicity assessment, bridging the gap between cellular
trials and mammalian experiments17,24 and facilitating the
translation of nanoformulations into a clinical setup.
5. Conclusions
Very high doses of DODAX :MO liposomes induce cytotoxicity
in human fibroblasts, associated with cell death markers
typical of apoptosis or necrosis, including exposure of phos-
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phatidylserine at the outer leaflet of the plasma membrane,
accumulation of ROS, alteration of the mitochondrial
membrane potential and plasma membrane disruption. The
counter ion of the cationic lipid plays a determinant role in
the elicited cytotoxicity: DODAC-based liposomes consistently
induce more adverse eﬀects, probably as a consequence of
stronger cell membrane destabilization. All liposomal formu-
lations have approximately the same size and surface charge,
but the presence of MO promotes a general beneficial eﬀect on
cell survival, especially in the DODAB : MO mixture (1 : 2).
Notably, an identical toxicity profile was obtained in vivo. Our
results highlight the importance of a dose-dependent evalu-
ation of the toxicity profile of liposomes, since diﬀerent assays
give diﬀerent sensitivities to DODAX :MO. This concentration/
molar fraction dependency was demonstrated to be relevant to
the embryotoxicity profile of DODAX and MO, either as free
components or in liposome formulations. Five other cell lines
give a consistent response to DODAX : MO liposomes in terms
of cellular metabolism and plasma membrane integrity.
In vivo, the monitoring of the early life of zebrafish allows the
detection of toxic signals induced by the diﬀerent nanoformu-
lations tested. The ZET assay reveals itself as highly appealing
for application in “intermediate” nanotoxicity profiling, after
initial screening in cultured cells and prior to validation in
mammalian models.
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